Citadel Advisors’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.4M Buy
5,810,642
+4,288,072
+282% +$67.7M 0.04% 1316
2025
Q4
$27.8M Sell
1,522,570
-596,592
-28% -$10.1M 0.02% 1987
2025
Q3
$31.1M Buy
+2,119,162
New +$36.3M 0.02% 1840
2025
Q2
Sell
-241,209
Closed -$4.92M 12344
2025
Q1
$4.79M Buy
241,209
+82,775
+52% +$1.43M ﹤0.01% 3950
2024
Q4
$2.72M Buy
+158,434
New +$2.98M ﹤0.01% 5011
2024
Q3
Sell
-30,351
Closed -$472K 14134
2024
Q2
$339K Sell
30,351
-264,338
-90% -$2.22M ﹤0.01% 8897
2024
Q1
$1.94M Buy
294,689
+59,931
+26% +$328K ﹤0.01% 5579
2023
Q4
$1.06M Sell
234,758
-632,585
-73% -$2.34M ﹤0.01% 6548
2023
Q3
$3.11M Buy
867,343
+812,084
+1,470% +$3.13M ﹤0.01% 4415
2023
Q2
$204K Sell
55,259
-187,437
-77% -$695K ﹤0.01% 9853
2023
Q1
$803K Buy
242,696
+90,076
+59% +$311K ﹤0.01% 7272
2022
Q4
$592K Sell
152,620
-210,137
-58% -$648K ﹤0.01% 7883
2022
Q3
$882K Buy
362,757
+201,530
+125% +$483K ﹤0.01% 7259
2022
Q2
$319K Sell
161,227
-76,419
-32% -$150K ﹤0.01% 9669
2022
Q1
$435K Sell
237,646
-380,603
-62% -$594K ﹤0.01% 9717
2021
Q4
$872K Buy
618,249
+461,861
+295% +$607K ﹤0.01% 8286
2021
Q3
$177K Buy
156,388
+28,373
+22% +$39.7K ﹤0.01% 12150
2021
Q2
$205K Sell
128,015
-92,447
-42% -$163K ﹤0.01% 12100
2021
Q1
$388K Buy
220,462
+69,683
+46% +$159K ﹤0.01% 10255
2020
Q4
$294K Buy
+150,779
New +$317K ﹤0.01% 9111
2020
Q3
Sell
-145,067
Closed -$398K 10003
2020
Q2
$425K Buy
145,067
+106,588
+277% +$306K ﹤0.01% 7345
2020
Q1
$111K Sell
38,479
-3,428
-8% -$11.8K ﹤0.01% 8561
2019
Q4
$168K Sell
41,907
-6,904
-14% -$30.1K ﹤0.01% 8298
2019
Q3
$217K Buy
48,811
+26,624
+120% +$111K ﹤0.01% 8047
2019
Q2
$86K Buy
+22,187
New +$97.9K ﹤0.01% 8577
2019
Q1
Hold
0
9198
2018
Q2
Sell
-12,890
Closed -$59K 8752
2018
Q1
$59K Buy
+12,890
New +$51.2K ﹤0.01% 7878

Other funds holding ADMA